Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10 million Series A financing round, led by Mercia.
Sphere Fluidics, a company developing single cell analysis systems, has announced that Biosyntia, a biotech company focused on synthetic biology and metabolic engineering, has adopted its Pico-Mine platform within its workflows.
Mekonos, a biotech platform developing cell therapies, has announced a new research collaboration with bit.bio, a synthetic biology company providing human cells for research, drug discovery and cell therapy.